Joy Y. Feng
Gilead Sciences
Inc, 333 Lakeside Drive
Foster City
USA
Name/email consistency: high
- The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study. Feng, J.Y., Ly, J.K., Myrick, F., Goodman, D., White, K.L., Svarovskaia, E.S., Borroto-Esoda, K., Miller, M.D. Retrovirology (2009)
- Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine. Feng, J.Y., Myrick, F.T., Margot, N.A., Mulamba, G.B., Rimsky, L., Borroto-Esoda, K., Selmi, B., Canard, B. Nucleosides. Nucleotides. Nucleic. Acids (2006)
- Effects of HIV Q151M-associated multi-drug resistance mutations on the activities of (-)-beta-D-1',3'-dioxolan guanine. Feng, J.Y., Myrick, F., Selmi, B., Deval, J., Canard, B., Borroto-Esoda, K. Antiviral Res. (2005)
- Anabolism of amdoxovir: phosphorylation of dioxolane guanosine and its 5'-phosphates by mammalian phosphotransferases. Feng, J.Y., Parker, W.B., Krajewski, M.L., Deville-Bonne, D., Veron, M., Krishnan, P., Cheng, Y.C., Borroto-Esoda, K. Biochem. Pharmacol. (2004)